Table 2.
Interventions by pharmacist | N (%) |
---|---|
Referred to for additional follow-up | 22 (40) |
Physician | 12 (22) |
PharmD | 10 (18) |
Medication-related problems identified | 22 |
Adherence | 7 |
Non-adherence | 3 |
More cost-effective medication available | 1 |
Patient unable to afford medication | 3 |
Safety | 5 |
Medication interaction | 1 |
Undesirable (adverse) effect | 3 |
Incorrect administration | 1 |
Unaddressed Indication | 3 |
Needs additional therapy | 3 |
Effectiveness | 2 |
More effective medication available | 1 |
Dosage form inappropriate | 1 |
Other | 5 |
Medication list updated | 44 (80) |
Instances of patient education provided | 66 |
Average reduction in systolic BP* | 4 mm Hg (± 19.6) |
Average reduction in diastolic BP* | 3 mm Hg (± 10.9) |
Average A1c at point 1 vs point 2** | 6.7 (± 0.9) vs 6.9 (± 1.4) |
*Patients with diagnosis of hypertension. **Patients with diagnosis of diabetes